SYLVESTER, Richard

Email Alert RSS Feed

Profile

Full Name
SYLVESTER, Richard
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Date Issued:  [1991 TO 1999]
Date Issued:  1997

Results 1-8 of 8 (Search time: 0.002 seconds).

Issue DateTitleContributor(s)TypeCat.
11997An introduction to the statistical design of phase III cancer clinical trialsSYLVESTER, RichardJournal Contribution
21997Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection aloneKurth, K.; Tunn, U.; Ay, R.; Schroder, F.; Pavone-Macaluso, M.; Debruyne, F.; ten Kate, F.; de Pauw, M.; SYLVESTER, RichardJournal Contribution
31997Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European organization for research and treatment of cancer randomized phase III trialBartelink, H.; Rubens, R.D.; van der Schueren, E.; SYLVESTER, RichardJournal Contribution
41997Analysis and presentationFriberg, S.; Taube, A.; SYLVESTER, Richard; Oesterling, J.E.Journal Contribution
51997Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a multi-institutional Medical Research Council/ European Organization for Research and Treatment of Cancer TrialHorwich, A.; Sleijfer, D.T.; Fossa, S.D.; Kaye, S.B.; Oliver, R.T.D.; Cullen, M.H.; Mead, G.M.; de Wit, R.; de Mulder, P.H.M.; Dearnaley, D.P.; Cook, P.A.; Stenning, S.P.; SYLVESTER, RichardJournal Contribution
61997Does isoniazed reduce side effects of intravesical Bacillus Calmette-Guerin therapy in superficial bladder cancer? Interim results of EORTC protocol 30911Vegt, P.; van der Meijden, A.; SYLVESTER, Richard; Brausi, M.; Holtl, W.; de Balincourt, C.Journal Contribution
71997Importance of bleomycin in combination chemotherapy for good prognosis testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Groupde Wit, R.; Stoter, G.; Kaye, S.B.; Steijffer, D.Th.; Jones, W.G.; ten Bokkel Huinink, W.W.; Rea, L.A.; Collette, L.; SYLVESTER, RichardJournal Contribution
81997Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminatomous testicular cancerde Wit, R.; SYLVESTER, Richard; Tsitsa, C.; de Mulder, P.H.M.; Sleyfer, D.T.; ten Bokkel Huinink, W.W.; Kaye, S.B.; van Oosterom, A.T.; Boven, E.; Stoter, G.Journal Contribution